HLB INC. Logo

HLB INC.

A biopharmaceutical company developing new global anti-cancer drugs.

028300 | KO

Overview

Corporate Details

ISIN(s):
KR7028300002
LEI:
Country:
South Korea
Address:
세종특별자치시 연동면 명학산단서로 10-5, 세종특별자치시

Description

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 00:00
주주명부폐쇄기간또는기준일설정
Korean 5.0 KB
2025-09-18 00:00
증권신고서(합병)
Korean 5.0 MB
2025-09-17 00:00
[첨부추가]주요사항보고서(회사합병결정)
Korean 42.9 KB
2025-09-16 00:00
주식등의대량보유상황보고서(일반)
Korean 129.4 KB
2025-09-08 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 11.2 KB
2025-09-03 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 41.0 KB
2025-09-01 00:00
주식등의대량보유상황보고서(일반)
Korean 138.5 KB
2025-09-01 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-28 00:00
증권발행결과(자율공시)
Korean 5.6 KB
2025-08-28 00:00
지속가능경영보고서등관련사항(자율공시)
Korean 11.1 KB
2025-08-20 00:00
주요사항보고서(전환사채권발행결정)
Korean 43.1 KB
2025-08-13 00:00
반기보고서 (2025.06)
Korean 3.8 MB
2025-08-01 00:00
[기재정정]주요사항보고서(회사합병결정)
Korean 47.6 KB
2025-08-01 00:00
기타경영사항(자율공시) (회사합병결정 철회에 관한 사항)
Korean 7.9 KB
2025-08-01 00:00
철회신고서
Korean 4.6 KB

Automate Your Workflow. Get a real-time feed of all HLB INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.